MREO
Mereo BioPharma Group plc
NASDAQ · Healthcare · Biotechnology · GB
$0.25
−8.16%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-98.0%
Return on equity
-80.9%
Return on assets
-115.1%
Return on invested capital
0.00x
Asset turnover
-$25.3M
Cash from operations
$0.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026